Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Avalia Immunotherapies

Avalia Immunotherapies
2015 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Early Stage VC LATEST DEAL TYPE
$2.07M LATEST DEAL AMOUNT
3 INVESTORS
Description

Developer of immunotherapies that support the treatment of cancer. The company's immunotherapies support the treatment of cancer, influenza, allergy, and other diseases. It also offers therapeutic vaccines that are intended for activating immune cells in the body.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Medical Supplies
Other Industries
Other Healthcare Services
Therapeutic Devices
Primary Office
  • 69 Gracefield Road
  • Lower Hutt, 5040
  • New Zealand

+64 04-566 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Avalia Immunotherapies’s full profile, request a free trial.

Avalia Immunotherapies Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 10-May-2016 $2.07M 00.000 Completed Startup
1. Accelerator/Incubator 21-May-2015 00000 00000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Avalia Immunotherapies Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
New Zealand Venture Investment Fund Fund of Funds Minority 000 0000 000000 0
Callaghan Innovation Accelerator/Incubator 000 0000 000000 0
Powerhouse Ventures (Christchurch) Venture Capital Minority 000 0000 000000 0

Avalia Immunotherapies Executive Team (3)

Name Title Board
Seat
Contact
Info
Shivali Gulab Ph.D Chief Executive Officer
Gavin Painter Ph.D Chief Technology Officer
Ian Hermans Ph.D Chief Scientific Officer

Avalia Immunotherapies Board Members (5)

Name Representing Role Since Contact
Info
Ashley Dunn Ph.D Avalia Immunotherapies Chairman 000 0000
Colin Dawson Powerhouse Ventures (Christchurch) Board Member 000 0000
Graham Le Gros MD Avalia Immunotherapies Board Member 000 0000
Melissa Yiannoutsos Avalia Immunotherapies Board Member 000 0000
Richard Furneaux Ph.D Avalia Immunotherapies Board Member 000 0000